BiOptic (Taiwan) Performance
| 6850 Stock | 44.50 2.00 4.71% |
The firm shows a Beta (market volatility) of 0.25, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BiOptic's returns are expected to increase less than the market. However, during the bear market, the loss of holding BiOptic is expected to be smaller as well. At this point, BiOptic has a negative expected return of -0.0719%. Please make sure to confirm BiOptic's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if BiOptic performance from the past will be repeated at some future point.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days BiOptic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BiOptic is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
BiOptic |
BiOptic Relative Risk vs. Return Landscape
If you would invest 4,750 in BiOptic on October 25, 2025 and sell it today you would lose (300.00) from holding BiOptic or give up 6.32% of portfolio value over 90 days. BiOptic is generating negative expected returns and assumes 2.5867% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than BiOptic, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BiOptic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BiOptic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BiOptic, and traders can use it to determine the average amount a BiOptic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Estimated Market Risk
| 2.59 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BiOptic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BiOptic by adding BiOptic to a well-diversified portfolio.
Things to note about BiOptic performance evaluation
Checking the ongoing alerts about BiOptic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BiOptic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BiOptic generated a negative expected return over the last 90 days |
- Analyzing BiOptic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BiOptic's stock is overvalued or undervalued compared to its peers.
- Examining BiOptic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BiOptic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BiOptic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BiOptic's stock. These opinions can provide insight into BiOptic's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for BiOptic Stock Analysis
When running BiOptic's price analysis, check to measure BiOptic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiOptic is operating at the current time. Most of BiOptic's value examination focuses on studying past and present price action to predict the probability of BiOptic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiOptic's price. Additionally, you may evaluate how the addition of BiOptic to your portfolios can decrease your overall portfolio volatility.